TriSalus Life Sciences, Inc. TLSI Change in fair value of contingent consideration
Change in fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s change in fair value of contingent consideration?
- TriSalus Life Sciences, Inc. (TLSI) reported change in fair value of contingent consideration of -$7.4M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s change in fair value of contingent consideration changed year-over-year?
- TriSalus Life Sciences, Inc.'s change in fair value of contingent consideration decreased by 1002.7% year-over-year, from $820K to -$7.4M.
- What does change in fair value of contingent consideration mean?
- Reflects the non-cash adjustment to the fair value of liabilities related to acquisition-based earnouts or contingent payments. Changes in this value indicate shifts in the probability or expected magnitude of future payouts to sellers. It provides insight into the long-term financial obligations tied to past business combinations.